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Out of 463 million people currently with diabetes, 232 million remain undiagnosed. Diabetes is a 
threat to human health, which could be mitigated via continuous self‑monitoring of glucose. In 
addition to blood, interstitial fluid is considered to be a representative sample for glucose monitoring, 
which makes it highly attractive for wearable on‑body sensing. However, new technologies are 
needed for efficient and noninvasive sampling of interstitial fluid through the skin. In this report, 
we introduce the use of Lorentz force and magnetohydrodynamics to noninvasively extract dermal 
interstitial fluid. Using porcine skin as an ex‑vivo model, we demonstrate that the extraction rate of 
magnetohydrodynamics is superior to that of reverse iontophoresis. This work seeks to provide a safe, 
effective, and noninvasive sampling method to unlock the potential of wearable sensors in needle‑free 
continuous glucose monitoring devices that can benefit people living with diabetes.
Diabetes causes 4 million deaths and costs 800 billion USD per year, affecting 463 million people globally. Addi-
tionally, 374 million people have impaired glucose tolerance (IGT), a high-risk state for  diabetes1. By 2030, the 
number of people with diabetes and IGT is projected to increase to 578 million and 454 million,  respectively2. 
Despite the high human, social, and economic cost that diabetes imposes on nations, diabetes awareness remains 
low and nearly 50% of all people with diabetes remain undiagnosed. Wearable devices for continuous self-
monitoring of glucose can play a crucial role in the fight against diabetes by promoting early detection, adequate 
management, and increased awareness of diabetes. However, widespread adoption of continuous glucose self-
monitoring requires further technological developments that improve user-friendliness and  performance3.
Blood glucose monitoring is essential for the diagnosis and management of  diabetes3–8. The main drawback 
of existing technology is the non-continuous mode and discomfort related to invasive blood sampling. Therefore, 
extreme glucose levels may remain unnoticed, which can compromise the health of diabetic persons. Therefore, 
much research is currently directed towards the development of noninvasive and wearable glucose sensors and 
monitoring  devices9–11.
Lately, there has been significant progress in the development of wearable sensors for continuous monitoring 
of glucose and other biomarkers in biofluids such as interstitial fluid, sweat, tears, and  saliva12–18. Among these 
biofluids, interstitial fluid (ISF) has a similar glucose concentration to blood plasma, while the concentration 
of glucose in saliva and sweat is much  lower14,54. From an analytical point of view, ISF is therefore an attractive 
sample for noninvasive glucose monitoring.  GlucoWatch® (Cygnus, Inc.)19, which was commercialized as a wear-
able glucose monitoring device, used reverse iontophoresis to extract ISF through skin. However, the device was 
withdrawn from the market in the late 2000s, indicating the great scientific and technological challenges related 
to noninvasive glucose  monitoring12–18. Despite intensive research and development, the market is still void of 
a noninvasive glucose  monitor12.
Measuring glucose concentrations for clinical purposes via noninvasive glucose monitoring has proven to be 
challenging. In recent years, extraction of ISF by reverse iontophoresis has received relatively little attention for 
glucose  monitoring20,21 compared to glucose measurements in  sweat22–28. Sweat is easily accessible but the sweat 
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rate and chemical composition of sweat varies greatly as a function of physical activity of the  person28. During 
physical exercise, sweat production is sufficiently high to allow for microfluidic sampling and  monitoring23–26. At 
rest, a sufficiently high rate of perspiration can be attained by locally activating sweat production through ionto-
phoretic delivery of substances such as pilocarpine, acetylcholine, or methacholine into the  skin28. Other nonin-
vasive approaches include glucose measurements in  tears29,30, while microneedles represent a minimally invasive 
option for measurements in  ISF31,32,33,34. All commercially available devices for continuous glucose monitoring, 
i.e. Guardian Connect CGM (Medtronic Inc.), Dexcom G6 (Dexcom Inc.), FreeStyle Libre (Abbott Diabetes 
Care Inc.), and Eversense CGM System (Senseonics Inc.) rely on invasive sampling of ISF using microneedles 
or subcutaneous  implants25,26,32,35. This indicates that, in addition to blood, ISF is a relevant biological fluid for 
glucose measurements.
Here, we present a novel method based on magnetohydrodynamics (MHD) for extraction of interstitial fluid. 
Magnetohydrodynamics is a physical phenomenon where fluid flow is induced by the Lorentz force generated by 
external magnetic and electric fields. The same physical mechanism has been used in other biomedical applica-
tions, e.g. in  micropumps36–38 and jet  injectors30,39. However, to our knowledge MHD is yet to be investigated as 
a physical mechanism to extract interstitial fluid from the skin.
Using porcine skin as an ex-vivo model, we show that MHD allows faster extraction compared to reverse 
iontophoresis. Furthermore, we show that the extracted glucose exhibits a linear relationship to the glucose con-
centration in a hydrogel in contact with the porcine skin, indicating the feasibility to use MHD as a quantitative 
tool. MHD increases the total amount of extracted glucose by a factor of two and the active extraction by a factor 
of 13 when compared to reverse iontophoresis. Hence, MHD reduces the amount of energy applied to the skin 
required for dermal interstitial fluid sampling and therefore potentially reduces the risk of skin reactions at the 
extraction site. In this instance, this extraction method is not specific to glucose. It could be applied to extract 
or deliver other diagnostically or therapeutically valuable molecules through the skin.
Results
Principle and experimental setup for MHD‑based extraction of interstitial fluid. To demon-
strate the efficacy of MHD, we performed experiments using an extraction cell (Fig. 1a) inspired by the work 
of Ching et al.40. We chose to use porcine skin, which is widely employed as a model of human skin for in vitro 
 studies41,42. Especially, stratum corneum from porcine ear has shown significant correlation to its human coun-
terpart in biophysical  properties42. To model the deeper skin layers, we used gelatin methacryloyl (GelMA) 
hydrogel because it mimics the collagen-rich extracellular  matrix43. We used an extraction cell featuring a lower 
and an upper chamber. We used an extraction cell featuring a lower and an upper chamber. The lower chamber 
(Fig. S2a) houses a two-layer skin model constructed from GelMA hydrogel, saturated with a solution of glucose 
of known concentration (Fig. S2b), and porcine ear skin (Fig. S2c). The upper part of the diffusion chamber, 
depicted in Figs. 1a and S2s, has three functions. Firstly, it creates a tight seal on the skin model, preventing any 
leakages. Secondly, it protects the hydrogel and skin from drying. And thirdly, provides a robust experimental 
setup for glucose extraction depicted in Figs. 1a and S2d. The upper part of the diffusion chamber features two 
cylindrical electrode wells (⌀ = 6 mm; height = 24 mm; separation = 4 mm) with square openings (l = 7 mm) fac-
ing the porcine skin. One electrode well was used as cathodic electrode (−) and one as anodic (+). This was 
determined by the direction of the applied current. Each well was filled with 400 µl of phosphate buffered saline 
(PBS, 10 mM, pH 7.4) (Fig. S2e) to conduct the electric current from the anodic Ag/AgCl wire through the skin 
and to the cathodic wire.
This extraction cell was positioned between two magnets to create a homogenous magnetic field across the 
cell (Fig. 1b). This magnetic field was combined with electric field to apply MHD extraction through our skin 
model. The extraction process and forces acting on the interstitial fluid in porcine skin graft are schematically 
presented in Fig. 1c. The electric field induces electro-osmotic flow from the anode, through the skin, and towards 
the cathode. The magnetic field orthogonal to the electric field induces a Lorentz force on the interstitial fluid and 
hence magnetohydrodynamic fluid flow from the deeper skin layers towards the outer skin surface. The extracted 
fluid accumulates in the electrode wells, and the glucose concentration was determined after each experiment. 
The experiments were carried out at room temperature and no self heating was detected.
Comparison of glucose extraction methods. We compared the amount of glucose actively extracted 
by MHD and reverse iontophoresis against passive diffusion (Fig. 2). The amount of glucose diffusing passively 
through the skin was measured using the same set-up that was used in the MHD and reverse iontophoresis 
experiments but without applying electric current or magnetic field. We chose reverse iontophoresis as a refer-
ence for active extraction because reverse iontophoresis is the most studied noninvasive method for extraction 
of glucose and other analytes from the  skin40,44–48. The amount of glucose extracted and collected in the cathodic 
electrode well was quantified using a colorimetric assay. We found that a large part of the measured glucose 
diffused passively to the electrode wells, and no clear difference between reverse iontophoresis and passive diffu-
sion was observed (Fig. 2a). However, there was a substantial increase in the amount of extracted glucose when 
MHD was applied. In order to determine the contribution of the active transport of glucose by MHD and reverse 
iontophoresis, the effect of diffusion was subtracted from the extraction data for both reverse iontophoresis and 
MHD. Accordingly, the estimated amount of glucose extracted actively with MHD (2.28 ± 0.32 µg) was 13 times 
higher than the amount of glucose extracted actively with reverse iontophoresis (0.17 ± 0.36 µg), when using 
10 min extraction time, 300 µA extraction current, and 300 mT for MHD.
The distribution of the current density in the MHD and reverse iontophoresis experiments depends on the 
size and morphology of the electrode areas, the electrode separation, and the impedance profile of the skin. In 
the case of MHD, the distribution of the electric current further depends on the strength and distribution of the 
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magnetic field. At constant electric energy deposition and constant electrode contact area, the distribution of 
the current density in the skin does not significantly affect the extraction efficiency according to the literature of 
reverse  iontophoresis45,49. For MHD, the distribution of the current density in the skin determines the distribu-
tion of the Lorentz force according to F = J × B. This may allow maximizing the energy efficiency of the extrac-
tion by optimizing the electrode morphology and the distribution of the magnetic field. Since the magnetic field 
was measured inside the empty cathodic electrode well, the exact distribution of the magnetic field across the 
GelMA hydrogel and the skin was unknown. However, the extraction cell was positioned at the center and in 
between the magnets, where the magnetic field is substantially homogenous. Furthermore, skin, water, air, and 
the materials of the set up (i.e. PMMA/Acrylic) feature similar relative magnetic permeabilities (μr ≈ 1). Hence, 
little distortion of the magnetic field induced by the different materials was expected.
During each extraction, we monitored the voltage between the extraction electrodes to investigate potential 
discrepancies in electric impedance in the skin samples. Figure 2c shows the measured voltage responses for 
reverse iontophoresis and MHD with different magnetic fields. For each condition, the voltage stayed relatively 
constant and the average voltage for each extraction was 0.24 V (Fig. S3). After each experiment, we counted the 
number of hair follicles inside the area of the electrode well (Fig. 2d) to investigate potential correlation between 
the number of hair follicles and the amount of extracted glucose. The number of hair follicles was between 5 
and 26. However, most skin samples featured 5 to 15 hair follicles. Even though the spread in the number of 
hair follicles per well area was relatively large, we observed no obvious correlation between the number of hair 
follicles and extracted glucose (Fig. 2e). Furthermore, we studied whether small differences in skin thickness 
affect the extraction (Fig. 2f). We chose skin thicknesses between 600 and 700 µm and observed no trends in 
the amount of glucose extracted with increasing skin thickness. However, the amount of glucose extracted dur-
ing 10 min depended on the glucose concentration in the GelMA hydrogel (Fig. 2g). This finding indicates that 
Figure 1.  (a) 3D model construction of MHD with the extraction cell cut out to reveal the main parts of the 
cell: GelMA hydrogel at the bottom, porcine skin on top of the hydrogel, electrode wells filled with buffer (PBS, 
10 mM, pH 7.4) and Ag/AgCl electrodes (ø = 1 mm, length = 2.5 cm). (b) The extraction chamber is positioned 
between two neodymium magnets (size: 70 mm × 70 mm × 30 mm). (c) Schematic picture of glucose extraction 
using MHD. An electric current is established between the two electrode chambers filled with buffer solution. 
The electric current induces electro-osmotic flow from the anode through the skin towards the cathode. A 
current density profile (J) in the presence of a magnetic field (B) generates a Lorentz force (F) that drives the 
interstitial fluid towards the skin surface.
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MHD could potentially be used in a quantitative manner with a suitable sensor to measure glucose levels in 
human interstitial fluid.
Extraction time optimization. To further investigate the glucose extraction from our porcine skin/
hydrogel skin model, we varied the extraction time while keeping the extraction current at 300 µA (Fig. 3a,b). 
As expected, the amount of extracted glucose increased with increasing extraction time for both extraction 
methods (Fig. 3a). However, after the effect of passive glucose diffusion was subtracted (Fig. 3b), the actively 
extracted amount of glucose remained relatively constant at 0.31 ± 1.1 µg, 0.54 ± 0.86 µg, and 0.17 ± 0.36 µg when 
using iontophoresis for 1 min, 5 min, and 10 min, respectively. In contrast, MHD achieved a significant increase 
in the amount of actively extracted glucose from 0.52 ± 0.88 µg to 2.50 ± 0.37 µg when increasing the extraction 
time from 1 to 5 min. Interestingly, the amount of actively extracted glucose remained relatively constant when 
further increasing the extraction time from 5 to 10 min. Hence, most of the glucose extracted with active meth-
ods (reverse iontophoresis and MHD) occurred during the first 5 min. This may be related to time-dependent 
changes in concentration gradients causing back-diffusion of glucose towards the hydrogel during prolonged 
extraction (Fig. 3b). Similar effects have been observed by others with urea, potassium, and cysteine as analytes 
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Figure 2.  (a) Measured amount of glucose collected in the cathodic electrode well after 10 min extraction 
with passive diffusion, reverse iontophoresis, and MHD using 125 mT, 200 mT and 300 mT magnetic fields. 
Each extraction was done at room temperature (22 ± 1 °C) using GelMA hydrogel with 5 mM glucose, and 
an extraction current of 300 µA. P-values were calculated using an unpaired t-test. (b) The amount of actively 
extracted glucose was calculated by subtracting the contribution of passive glucose diffusion. (c) Measured 
voltage curves during extraction. Voltage between the extraction electrodes was measured during each 
extraction. (d–f)Amount of extracted glucose in relation to the number of hair follicles and thickness of the skin 
samples. (d) Pictures from a porcine skin sample after extraction at the electrode well area, where the individual 
hair follicles are marked with arrows. (e) Number of hair follicles and total amount of glucose measured 
(extraction + diffusion) for both iontophoresis and MHD with 300 mT magnetic field. (f) Thickness of porcine 
skin and total amount of glucose measured (extraction + diffusion) for both iontophoresis and MHD with 300 
mT magnetic field. (g) Total extracted glucose with different glucose concentrations in the GelMA hydrogel 
(p = 0.0002 from an F-test) (B = 300 mT, I = 300 µA). In figs (a–c) the bars show the average from at least 6 
individual experiments and the error bars represent standard deviation of the mean.
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Skin damage assessment. Potential damage to the skin induced by either MHD or reverse iontophoresis 
was investigated with trans-epidermal water loss measurements (TEWL)52,53 and visual inspection performed 
before and after the extraction (Fig. 4a). Average TEWL measurements after the extraction were slightly higher 
than before the extraction for MHD, reserve iontophoresis, and passive diffusion (Fig. 4b). Reverse iontopho-
resis showed higher average ΔTEWL when compared to MHD and passive diffusion. However, there was no 
statistical difference between the extraction and reference experiments, which indicates that the increase was 
caused by the highly hydrated conditions in the extraction cell. This implies that neither of the extraction meth-
ods affect the skin barrier function.
Discussion
We presented a novel extraction method for interstitial fluid sampling that relies on MHD and the Lorentz 
force. Utilizing glucose as the analyte and a well-established substitute for human skin, the porcine ex vivo skin 
model, we compared the efficiency of MHD and reverse iontophoresis to passive diffusion under well-defined 
experimental conditions. The results showed that the efficiency of the MHD extraction method is superior to that 
of reverse iontophoresis. Using a 300 mT magnetic field we achieved a 13-fold increase in active glucose extrac-
tion. Furthermore, the amount of extracted glucose was proportional to the glucose concentration in the sample, 
which is important when considering potential applications in glucose sensing where the extracted amount of 
glucose in ISF is expected to correlate with the concentration of glucose in blood. Transepidermal water loss 
measurements before and after extraction showed no significant differences, implying that the extraction does 
not damage the skin permeability barrier. In this paper, we reported relatively high values of diffusion when 
compared to the active extraction. This indicates that the porcine skin grafts were probably more preamble than 
intact human skin. Thus, this study encourages more research into ex vivo models which could better represent 
the effect of microcirculation and barrier function of living skin.
The proposed technology can be optimized by exploring different electrode shapes, sizes, and distances, in 
addition to extraction current waveforms, to increase the glucose extraction rate obtained with MHD. Moreo-
ver, the magnet arrangements can be decreased in size if the magnets are moved closer to the skin surface. For 
example, when using a Neodymium magnet as small as 5 mm × 5 mm, a magnetic field of 265 mT is present 
at the surface of the magnet  (Fig. S7). Thus, the MHD technology has the potential to be applied in wearable 
devices for noninvasive glucose monitoring. These small magnets could be installed into a portable device such 
as a wrist band or sport watch with glucose sensitive electrodes.
Since the MHD technology is non-selective, these findings imply that the MHD method could potentially be 
used to extract other analytes present in ISF (e.g.  Na+,  K+, and lactate) which could be of interest in biomarker 
sensing. Furthermore, the extraction rate achieved with MHD could enable detection of sparse analytes, such 
as cortisol, that exist in interstitial fluid at concentrations below 1 µM54. Consequently, the presented MHD 
extraction method could be valuable to the development of wearable chemical sensors and biosensors utilizing 























































Figure 3.  (a) The effect of extraction time on total amount of extracted glucose for diffusion, reverse 
iontophoresis (300 µA) and MHD (300 µA and 300 mT). The bars represent the average from at least 4 
individual experiments and the error bars represent standard deviation of the mean. The values of individual 
experiments are indicated with the circles on top of the bar graphs. Dotted line on the bar graphs serves as a 
guide for the eye and represent the contribution of diffusion. The p-values were calculated using an unpaired 
t-test. (b) Amounts of actively extracted glucose after the effect of passive glucose diffusion is subtracted. This 
data indicates that MHD extraction is more effective that reverse iontophoresis also in shorter extraction times. 
Furthermore, most of the active extraction occurring at the early time points of the extraction.
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current, the direction of the magnetohydrodynamic force can be reversed. Thus, this technology could potentially 
also be used to deliver molecules through the skin and into the human body.
In conclusion, we anticipate that the results presented in this work may encourage researchers to revisit the 
utilization of ISF as a sample for noninvasive on-body chemical sensing.
Methods
Synthesis of gelatin methacryloyl (GelMA). GelMA was synthetized by functionalising gelatin from 
bovine skin (type B, Sigma Aldrich) with methacrylic anhydride (MEA, Sigma Aldrich) using a protocol adapted 
from ref.55. Briefly, 10% gelatin solution was prepared by dissolving gelatin powder into PBS (pH 7.4) at 50 °C. 
While vigorously stirring, 0.6 g of MEA per 1 g of gelatin was added dropwise into the gelatin solution and the 
reaction was stirred at 50 °C for 3 h. Unreacted MEA was removed by 5 min centrifugation at 2180 G followed 
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Figure 4.  (a) Photographs of porcine skin samples used in this study either with reverse iontophoresis or MHD. 
No damage apart from minor imprints from the electrode wells were visible. (b) Skin water loss was measured 
at room temperature using a Tewameter before and after extraction (delta = after extraction-before extraction). 
The Tewameter readings measured after reverse iontophoresis (n = 22) and extraction with MHD (n = 23) were 
not statistically different from the values measured for samples where no active extraction was applied (n = 17). 
Individual data points are represented with circles and the boxes behind the data points represent the standard 
error. The thin, horizontal lines mark the mean values, and the error bars depict standard deviation of the 
dataset. The p-values were calculated using an unpaired t-test.
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− 20 °C. The degree of functionalization (DOF) in GelMA synthesis was measured using an OPA (o-phthalalde-
hyde)  assay55 and 86% DOF was achieved.
Preparation of GelMA hydrogel. The protocol for GelMA hydrogel preparation was adapted from ref.56. 
GelMA hydrogel was prepared from 10% GelMA solution (in PBS, pH 7.4) with 0.15% of lithium phenyl-2,4,6-
trimethylbenzoylphosphinate photoinitiatior (LAP). The mixture was placed in a hand casting mold (Mini-
PROTEAN® Tetra Handcast System, Biorad) with a 1.5 mm spacer and was polymerized with UV-C light (Car-
bon XM-120V, Green UV) for 5 min. The crosslinked GelMA was placed into PBS to remove residues of LAP. 
For doping the gel with glucose, the GelMA powder was dissolved into PBS with glucose and the hydrogels were 
made as previously described. Crosslinked GelMA hydrogels were then stored in PBS with glucose until used.
Preparation of porcine skin. We purchased the porcine ears from a local eco farm (Kiven säästöpossu, 
Karkkila, Finland). We collected the ears from the slaughterhouse, where the ears remained at room temperature 
for 2 h after sacrificing the animals. Afterwards, the ears were transported on ice for 1 h. Then, the ears were 
washed with cold running water. From the posterior surface of each ear, 2 to 3 round samples of 4 cm diameter 
and between 600 and 700 µm thickness (Fig. S4) were dissected using a dermatome (Nouvag, Switzerland). Indi-
vidual skin samples were wrapped in parafilm and stored at – 20 °C and were used within the next two weeks. 
Trans-epidermal water loss was measured before freezing and after defrosting to track damage of the skin dur-
ing skin sample storage (Fig. S5). The measurements were done with a  Tewameter® (TM 300, Courage + Khaz-
aka electronic GmbH, Germany) using the software (MPA WL version 1.3.1) according to the manufacturer’s 
instructions. An example of a  Tewameter® reading is shown in Fig. S5. After defrosting, the skin samples were 
equilibrated at room temperature (22 ± 1 °C) in PBS for 1.5 h with changing the buffer every 30 min. Extra buffer 
on the skin surface was removed by absorbing it with paper tissue before each experiment.
Silver wire chlorination. Silver wires (diameter = 1.0  mm, Sigma Aldrich) were cleaned with 120-grit 
sandpaper and rinsed with water and 2-propanol. The clean wires were placed in a 1 M KCl bath and 300 µA 
current was passed through them for 3 h. After chlorination, the wires were rinsed with deionized water, dried 
gently with pressurized air, and stored protected from light.
Experiments with extraction cell. All measurements and experiments were done at 22 ± 1 °C. A two-
layer hydrogel skin model was constructed in an extraction chamber (Fig. S1) by carefully placing a piece of 
GelMA hydrogel 1.5 mm thick and 3 cm in diameter with a specific glucose concentration into the extraction 
chamber. A porcine skin sample (thickness: 600 to 700 µm; ø = 4 cm) was placed on top of the GelMA (care 
was taken to avoid trapping air between the layers). Then, the diffusion chamber was tightly sealed with plastic 
screws. Subsequently, the electrode wells were filled with 400 µl of PBS (pH 7.4, Sigma Aldrich) and the Ag/
AgCl electrode wires were immersed into the buffer solution avoiding contact with the walls of the well. A 
current of 100, 200 or 300 µA was passed through the electrodes using a current source (Model 6220, Keithley 
Instruments). For MHD extraction, the set up was placed at the center and in between two or more magnets 
(neodymium magnets, Goliath, Supermagnete) which established a homogeneous magnetic field at the extrac-
tion site. The set of magnets were positioned carefully so that the magnetic field was perpendicular to the current 
field thereby causing the Lorenz force predominantly orthogonal to and pointing away from the skin surface. 
The two highest magnetic fields were obtained by placing the extraction chamber in the middle of an ensemble 
of four magnets (Fig. S1). The magnetic field strength was measured inside an empty electrode well with an AC/
DC magnetic meter (PCE-MFM 3000). Trans-epidermal water loss was measured before and after extraction to 
track potential damage of the skin during extraction experiments. The water-loss measurements were conducted 
with a  Tewameter® (TM 300, Courage + Khazaka electronic GmbH, Germany).
Determination of glucose concentration. The glucose concentration was measured using a protocol 
adapted from ref.57. Accordingly, 125 µl samples were taken from the electrode wells and mixed with 250 µl of 
reaction mixture containing 12.8 U/ml of glucose oxidase, 2.6 U/ml of horse radish peroxidase, and 0.13 mg/ml 
of o-dianisidine in PBS (pH 7.4). This mixture was incubated at 37 °C for exactly 30 min. Immediately thereafter, 
250 µl of 12% sulfuric acid was added to the mixture. The light absorbance of the reaction product, oxidized 
o-dianisidine, was measured at 540  nm using a UV–VIS spectrophotometer (UV-1900, Shimadzu) and was 
compared to the standard curve (Fig. S6).
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